4.8 Article

Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission

Journal

NATURE COMMUNICATIONS
Volume 11, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41467-020-19741-6

Keywords

-

Funding

  1. Crick African Network, African Career Accelerator Award [CANB0001/01]
  2. Centre of Excellence (Centre for Adolescent Rheumatology Versus Arthritis) [21593]
  3. Medical Research Council [MR/R013926/1]
  4. Great Ormond Street Children's Charity
  5. NIHR Biomedical Research Centre at University College London Hospital [BRC/III 525]
  6. Medical Research Foundation Lupus Fellowship [MRF-057-0001-RG-ROSS-C0797]
  7. NIHR Biomedical Research Centre at Great Ormond Street Hospital
  8. Versus Arthritis Studentship [22203]
  9. MRC [MR/P028071/1] Funding Source: UKRI

Ask authors/readers for more resources

Anecdotal evidence suggests that Coronavirus disease 2019 (COVID-19), caused by the coronavirus SARS-CoV-2, exhibits differences in morbidity and mortality between sexes. Here, we present a meta-analysis of 3,111,714 reported global cases to demonstrate that, whilst there is no difference in the proportion of males and females with confirmed COVID-19, male patients have almost three times the odds of requiring intensive treatment unit (ITU) admission (OR=2.84; 95% CI=2.06, 3.92) and higher odds of death (OR=1.39; 95% CI=1.31, 1.47) compared to females. With few exceptions, the sex bias observed in COVID-19 is a worldwide phenomenon. An appreciation of how sex is influencing COVID-19 outcomes will have important implications for clinical management and mitigation strategies for this disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available